Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026Business Wire · 5 days ago
Stevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha · Sep 15, 2026
Stevanato Group to Participate in Two Upcoming Investor ConferencesBusiness Wire · Sep 8, 2026
A Look at Stevanato Group SpA (STVN) After 3.4% Decline -- GF Value $25.98 vs Price $20.71GuruFocus · Sep 1, 2026
Stevanato Group: Alina Validates The Container-To-Device FlywheelSeeking Alpha · Aug 29, 2026
Stevanato Group SpA (STVN) Shares Fall 5.7% -- What GF Score of 87 Tells InvestorsGuruFocus · Aug 28, 2026Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | $0.14 | $0.16 | Beat |
| May 7, 2026 | $0.12 | $0.13 | Beat |
| Mar 4, 2026 | $0.20 | $0.21 | Beat |
| Nov 6, 2025 | $0.14 | $0.16 | Beat |
| Aug 5, 2025 | $0.11 | $0.12 | Beat |
| May 8, 2025 | $0.10 | $0.11 | Beat |